P-175 Oncolytic Virus Therapy in Pancreatic Cancer: Clinical Efficacy and Pharmacodynamic Analysis of REOLYSIN in Combination with Gemcitabine in Patients with Advanced Pancreatic Adenocarcinoma
Devalingam Mahalingam(The University of Texas at San Antonio Health Science Center), M. Mita(Samueli Institute), Giovanni Selvaggi, Sanjay Goel(Rutgers, The State University of New Jersey), Steffan T. Nawrocki(University of Arizona), Matt Coffey(Oncolytics Biotech (Canada)), Gerard J. Nuovo(CS Diagnostics), Nicole Noronha(Oncolytics Biotech (Canada))
Cited by 8
Related Papers
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
|Translational research|2020|2.3k
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782